Ignite Creation Date:
2024-05-05 @ 9:37 PM
Last Modification Date:
2024-10-26 @ 10:07 AM
Study NCT ID:
NCT00923910
Status:
COMPLETED
Last Update Posted:
2017-04-12
First Post:
2009-06-17
Brief Title:
Wilms Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Hodgkins Lymphoma NHL |
| Leukemia Acute Myelogenous AML |
| Leukemia Acute Lymphocytic ALL |
| Leukemia Chronic Myelogenous CML |
| Myelodysplastic Syndrome MDS |
Keywords:
| Name | View |
|---|---|
| Non-Hodgkin Lymphoma | View |
| WT1 Peptide Dendritic Cell Vaccine | View |
| Hematologic Malignancies | View |
| Relapse After Allogeneic Stem Cell Transplantation | View |
| Donor Lymphocyte Infusions | View |
| WT1-Positive | View |
| Dendritic Cell Vaccine | View |
| Tumor Immunotherapy | View |
| Allogeneic Adoptive Immunotherapy | View |
| Hodgkins Lymphoma | View |
| Leukemia | View |
| Acute Myelogenous Leukemia | View |
| AML | View |
| Acute Lymphocytic Leukemia | View |
| ALL | View |
| Chronic Myelogenous Leukemia | View |
| CML | View |
| Myelodysplasia Syndrome | View |